Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: A mechanistic insight

Resveratrol (RSVL), a well known dietary compound and in combination with doxorubicin (DOX) has gained a global importance for cancer prevention. However, mechanism of action by this combination is not well understood till date. The synergistic combination of RSVL and DOX might be more effective in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Phytomedicine (Stuttgart) 2016-03, Vol.23 (3), p.233-242
Hauptverfasser:	Rai, Girish, Mishra, Sanjay, Suman, Shankar, Shukla, Yogeshwer
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Animals Anthracyclines Antineoplastic Agents - pharmacology Apoptosis Apoptosis - drug effects Apoptosis Regulatory Proteins - metabolism Autophagy - drug effects Breast cancer Cancer Carcinoma, Ehrlich Tumor - pathology Care and treatment Cell Cycle - drug effects Cell Line, Tumor Cell signaling Cytotoxicity Doxorubicin Doxorubicin - pharmacology Ehrlich ascitic carcinoma Female Humans Male Mice NF-kappa B - metabolism Photographic industry Prevention Resveratrol Stilbenes - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!